(Q77349947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

S Bar-Meir

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Y Chowers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Lavy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

D Abramovitch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A Sternberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G Leichtmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Reshef

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

S Odes

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Moshkovitz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Bruck

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R Eliakim

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

E Maoz

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

U Mittmann

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

English

0 references

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

835-840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970254-9

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970254-9

A comparison of budesonide with prednisolone for active Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970254-9

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970254-9

10.1016/S0016-5085(98)70254-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753485%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference